{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-344583","form_type":"8-K","ticker":"ANAB","cik":"0001370053","company_name":"ANAPTYSBIO, INC","filed_at":"2026-08-11T20:05:17+00:00","discovered_at":"2026-08-11T20:06:00.542478+00:00","generated_at":"2026-08-11T20:06:08.021541+00:00","sec_items":["5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.15,"confidence":"high","headline":"AnaptysBio annual meeting: directors elected, KPMG ratified, equity plan amended","bullets":["Stockholders elected Hollings Renton (15,304,522 for) and John P. Schmid (20,314,669 for) as Class III directors for 3-year terms.","Ratified KPMG LLP as independent auditor for fiscal year ending June 30, 2027: 22,343,352 votes for.","Advisory say-on-pay approved: 21,274,791 votes for; 609,979 against.","Approved amendment to 2017 Equity Incentive Plan extending term 10 years from Aug 11, 2026 and capping non-employee director comp at $1M (first year) / $750K (subsequent years)."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-344583","json":"https://secwatch.observer/filing/0001193125-26-344583.json","markdown":"https://secwatch.observer/filing/0001193125-26-344583.md","text":"https://secwatch.observer/filing/0001193125-26-344583.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1370053/000119312526344583/0001193125-26-344583-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1370053/000119312526344583/anab-20260811.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-11T20:06:08.021541+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}